TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Neutropenia
Studies from O. Penack and colleagues reveal new findings on neutropenia
June 17th, 2008
"We carried out a prospective study on galactomannan enzyme immuno assay ( GEI) ( Platelia (TM) Aspergillus EIA, Bio- Rad) testing for diagnosis of invasive aspergillosis ( IA) in serum and broncho- alveolar lavage ( BAL) in 200 patients with hematological malignancies and profound neutropenia. The incidence of proven and probable IA was 6% and 5.5%, respectively," investigators in Berlin, Germany report. "In patients with fever or pneumonia, a single- positive GEI test result ( galactomannan index >= 0.5) had excellent specificity ( 100%). Sensitivity was relatively low ( 40%) at onset of fever, but increased to 94.7% after 6 days of fever. In patients with...
Source: TB & Outbreaks Week (2008-06-17)
|
